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Abstract
Transcriptional profiling highlighted a subset of genes encoding putative multidrug transporters in the pathogen Bacillus
cereus that were up-regulated during stress produced by bile salts. One of these multidrug transporters (BC4707) was
selected for investigation. Functional characterization of the BC4707 protein in Escherichia coli revealed a role in the
energized efflux of xenobiotics. Phenotypic analyses after inactivation of the gene bc4707 in Bacillus cereus ATCC14579
suggested a more specific, but modest role in the efflux of norfloxacin. In addition to this, transcriptional analyses showed
that BC4707 is also expressed during growth of B. cereus under non-stressful conditions where it may have a role in the
normal physiology of the bacteria. Altogether, the results indicate that bc4707, which is part of the core genome of the B.
cereus group of bacteria, encodes a multidrug resistance efflux protein that is likely involved in maintaining intracellular
homeostasis during growth of the bacteria.
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Introduction
Bacillus cereus sensu lato (the Bacillus cereus group of bacteria) are
Gram-positive rod-shaped bacteria that readily form endospores
under unfavorable growth conditions. They comprise six pheno-
typically diverse, but genetically closely related, species - B. cereus
sensu stricto, B. anthracis, B. thuringiensis, B. weihenstephaniensis, B
mycoides and B. pseudomycoides [1]. Among these bacteria, the last
three species are generally considered non-pathogenic. B.
thuringiensis is an insect pathogen commercially used as a
biopesticide. B. anthracis is notorious for being the agent causing
anthrax in humans and animals [2] as well as for its potential role
in biological warfare including bioterrorism [3]. B. cereus sensu stricto
(from now on referred to as B. cereus) is primarily associated with
food borne, self-limiting gastrointestinal infections. It is also an
opportunistic pathogen that causes local infections following
trauma as well as systemic diseases in predisposed patients [4–6].
Although B. cereus is commonly reported as a soil bacterium, the
life style is not completely understood. Spores have been isolated
from different types of soil [7] as well as faeces of healthy humans
[8,9]. There are reports of B. cereus found in the rhizosphere of
plants [10] and guts of invertebrates [11]. The current view is that
soil-dwelling spores germinate and grow, either in an animal host
or in the rhizosphere of plants, suggesting that the natural lifestyle
of B. cereus often involves symbiotic or pathogenic interactions with
animals and plants. The diverse environments where B. cereus is
found suggest that these bacteria survive and grow in competition
with other microorganisms as well as in a range of challenging
conditions such as different temperatures, extremes of pH and
toxic compounds.
In order to survive challenging extracellular conditions, it is
essential to maintain homeostasis in the intracellular environment.
This is partly achieved through the action of different types of
membrane proteins that transport nutrients and ions into the cell
and excrete waste products and toxic compounds from the cell.
According to the transportdb database [12,13] the B. cereus type
strain (ATCC14579) has 390 putative membrane transporters,
including approximately 100 predicted multidrug transporters.
The high number of predicted membrane transporters encoun-
tered in B. cereus species may well reflect the diverse environments
where they are found.
Multidrug transporters are energy dependent membrane
proteins that extrude a wide array of structurally and functionally
dissimilar compounds. Multidrug transporters play a significant
role in resistance of bacteria to antimicrobial compounds [14–16].
It has also been suggested that multidrug transporters have
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36720
additional/alternative roles in the normal physiology of bacteria,
facilitating survival in their ecological niche [17–19]. Multidrug
transporters are categorized into five superfamilies [20] i. Major
Facilitator Superfamily (MFS), ii. Resistance nodulation cell
division (RND), iii. Small multidrug resistance (SMR), iv.
Multidrug and toxic compound extrusion (MATE) and v. ATP-
binding cassette (ABC). The ABC transporters use the energy from
ATP hydrolysis directly to force drug expulsion. The other four
families of multidrug transporters are secondary metabolite
transporters driving drug efflux with either the proton or sodium
gradients that are established across the cytoplasmic membrane of
cells during respiration (or by ATP hydrolysis in strictly
fermentative organisms). Although at present, most of the
transporters encoded in B. cereus remain uncharacterized, it was
shown that a set of membrane transporters, including several
putative multidrug transporters were upregulated in B. cereus
ATCC14579 when challenged with sub-lethal concentrations of
bile salts [21]. In addition, a partly overlapping set of transporters
was induced by sub-lethal concentration of acetic acid [22].
Bacteria would encounter similar stress during passage through the
gastrointestinal tract, suggesting that these transporters could be
part of a survival system expressed in bacteria in order to inhabit
such hostile environments.
In this study, we initiated the biochemical and functional
characterization of one putative multidrug transporter (BC4707)
shown to be induced by sub-lethal concentrations of both bile salts
and acetic acid; by cloning, expressing and characterizing its
activities in an E. coli host. In parallel, we deleted the gene (bc4707)
and examined its role in the B. cereus ATCC14579 under non-
stressful conditions such as exponential growth in LB-medium as
well as stressful conditions including bile salts stress, metabolic
stress, antibiotics and low pH.
Results
BC4707 is not essential for B. cereus to survive bile salts
stress
Induction of bc4707 transcription in B. cereus upon bile salt stress
[21], suggested a role in bile salts efflux. To test the role of BC4707
in bile salts protection, a markerless Dbc4707 mutant was
constructed in B. cereus ATCC14579 and the two strains were
compared under growth in LB medium as well as under bile salts
stress. It was revealed that although growth of the bacteria was
repressed in the prescence of 50 mg/ml bile salts the Dbc4707
mutant and the wild type grow in a similar fashion (Fig. 1). This
result indicated that although bc4707 expression is induced under
bile salts stress, the protein is not essential for bile salts protection.
Transcriptional profiling suggests that BC4707 is not
involved in protection of B. cereus against bile salts stress
Considering that bc4707 expression was induced by bile salts
stress whereas BC4707 was non-essential for growth in the
presence of sub-lethal concentrations of bile salts, we hypothesized
that a compensatory mechanism was induced in the Dbc4707
mutant under such conditions. In order to test for compensatory
mechanisms, a series of microarray analyses were performed
comparing the transcriptional profiles of the wild type B. cereus and
the Dbc4707 mutant under bile salts stress. Bacteria were grown to
an OD600 of 0.5. At this point bile salt was added to a
concentration of 50 mg/ml and the cultures were incubated for
15 additional minutes. RNA was prepared for each strain at
OD600 of 0.5 (WT
OD0.5, mutantOD0.5) as well as after 15 min bile
salts stress (WTBS15, mutantBS15). To determine the bile salt
induced stress response in LB medium, the mRNA content of the
bile salt stressed cells was compared to the mRNA content of the
pre-stressed cells by microarray analysis (i.e. WTBS15 was
compared to WTOD0.5 and mutantBS15 was compared to
mutantOD0.5. Arrayexpress accession numbers E-MEXP-3535
and E-MEXP-3536 respectively). These microarray analyses
demonstrated a substantial stress response in both the wild type
and the Dbc4707 mutant (Table S1), with significant differential
regulation of approximately 10% of the genome, including at least
10 efflux proteins (counting bc4707 in the wt strain, see also
Kristoffersen et al. [21]). The transcriptional profiles of the wild
type and mutant after 15 min bile salts stress were similar (Table
S1) with few and negligible differences between the two data sets.
To identify potential compensatory mechanisms that allow the
Dbc4707 mutant to grow similar to the wild type under bile salt
stress, the mRNA content of the Dbc4707 strain after bile salts
stress for 15 min (mutantBS15) was compared to the corresponding
mRNA of the wild type (WTBS15). This microarray analysis
(Arrayexpress accession number E-MEXP-3529) confirmed that
there are few differences between the two strains in the bile salts
induced stress response (Table 1). Four genes were differentially
expressed more than 1.5-fold. Three of these genes were up-
regulated in the Dbc4707 mutant: bc2989 annotated as a
hypothetical protein; bc4111, which, from sequence similarity, is
described as a bifunctional 3,4-dihydroxy-2-butanone 4-phosphate
synthase/GTP cyclohydrase II protein, involved in riboflavin
synthesis; and bc4904, annotated as a hydrolase of the alpha/beta
fold family. Furthermore, the cold shock protein CspD (bc4859),
was down regulated in theDbc4707 mutant compared to the wild
type. This indicates that the absence of BC4707 does not induce a
major compensatory response to bile salts stress at the mRNA
level.
BC4707 is not involved in the acid stress defense of B.
cereus
According to Mols et al. bc4707 is slightly up-regulated under
sub-lethal acetic acid stress [22], indicating a potential role for
Figure 1. Comparison of the growth of Bacillus cereus
ATCC14579 and its isogenic Dbc4707 mutant. Growth was
assayed for the wild type (circles) and the mutant (squares) by
monitoring the absorbance at 600 nm in LB medium (solid lines; closed
symbols) and during 50 mg/ml bile salts stress initiated at OD600 of 0.5
(dashed lines; open symbols). Shown are averages and standard
deviations of two independent experiments.
doi:10.1371/journal.pone.0036720.g001
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BC4707 in maintaining the intracellular pH of B. cereus in an acidic
environment. To test this, the experiments described by Mols et al.
were reproduced. Bacteria were grown in a neutrally buffered BHI
medium to mid-logarithmic phase, at which point the medium was
acidified and the OD was measured for an additional 4.5 hours.
No difference was observed between the wild type and Dbc4707
mutant (data not shown), indicating a non-essential role for
BC4707 under acetic acid shock.
Inactivation of the bc4707 gene renders B. cereus more
susceptible to norfloxacin
To elucidate the role of BC4707 in B. cereus drug tolerance, the
markerless knock out mutant was compared to the wild type in
susceptibility assays (Table 2). The Dbc4707 mutant and wild type
strains only differed in the sensitivity to one (norfloxacin) of 12
toxic compounds tested. The two-fold difference in susceptibility to
norfloxacin was consistent between the wild type and Dbc4707
mutant. Growth curves of the wild type and mutant supplemented
with a sub-lethal concentration of norfloxacin, demonstrated a
moderate, but consistent reduction in growth of the Dbc4707
mutant compared to the wild type (Fig. 2). Taken together,
BC4707 is involved in norfloxacin tolerance of B. cereus
ATCC14579.
Microarray analysis suggests a physiological role for
BC4707 in exponential growth of B. cereus
Although bioinformatics analysis has predicted BC4707 to be a
multidrug transporter, susceptibility testing of the Dbc4707 mutant
only identified norfloxacin as a potential substrate (Table 2). A few
multidrug transporters have been shown to have physiological
functions in addition to multidrug efflux [17,18,23–25]. The large
number of putative multidrug transporters in B. cereus suggests
alternative or additional functions to multidrug efflux for some of
these transporters, possibly under conditions that do not impose
exogenous stress on the bacteria. We therefore measured the
transcription level of bc4707 under logarithmic growth in rich
medium. Quantitative RT-PCR analysis at different time points of
B. cereus ATCC14579 growing in LB medium indicated that
although the absolute expression level of bc4707 is relatively low
(data not shown) it is increasingly expressed during logarithmic
phase up to the onset of the transition preceding stationary phase
Table 1. Transcriptional profile of B. cereus ATCC14579 Dbc4707 (AH1598) compared to wild type (AH1709) grown to logarithmic
stage (OD600,0.5) in rich medium followed by bile salt stress for 15 min.
Gene Predicted protein function Dbc4707/WT
(fold change)
bc2989 Hypothetical protein 1.68
bc4111 Bifunctional 3,4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrase II
protein
1.51
bc4707 drug resistance transporter, EmrB/QacA family 0.32
bc4859 Cold shock protein CspD 0.61
bc4904 Hydrolase, alpha/beta fold family 1.96
doi:10.1371/journal.pone.0036720.t001
Table 2. Susceptibilities of B. cereus ATCC14579 (wild type)
compared to its isogenic Dbc4707 mutant.
MIC (mg/ml)
B. cereus ATCC14579
Compound Wild type Dbc4707 1
Chloramphenicol 2.5 2.5 1
Ciprofloxacin 0.32 0.32 1
Bile salts 125 125 1
Deoxycholate 250 250 1
SDS 100 100 1
Crystal violet 0.1 0.1 1
Kanamycin 15 15 1
Nalidixic acid 1.875 1.875 1
Erythromycin 0.2 0.2 1
Ethidium bromide 40 40 1
Norfloxacin 1.25 0.625 2
Tetracycline 2.5 2.5 1
1represents the fold difference in MIC between the wild type B. cereus
ATCC14579 and its isogenic Dbc4707 mutant.
doi:10.1371/journal.pone.0036720.t002
Figure 2. Growth of B. cereus ATCC14579 and Dbc4707 mutant
under stress with sublethal concentration of norfloxacin. Over
night cultures were diluted 1:100 and grown to mid-logarithmic phase.
These cultures were diluted to OD600 of 0.02 in 25 ml LB and norfloxacin
was added. The cultures were incubated for 240 min at 30uC and
220 rpm shaking. The growth curves show averages and standard
deviations of two independent experiments.
doi:10.1371/journal.pone.0036720.g002
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in B. cereus (Fig. 3). The increasing expression of bc4707 during
logarithmic phase supported the hypothesis of a potential role for
BC4707 under exogenously imposed non-stressful growth condi-
tions. Growth of the Dbc4707 mutant in LB-medium, however,
was identical to the growth of the wild type strain (Fig. 1),
suggesting a non-essential role for BC4707 in rich medium.
Potentially, overlapping functions of constitutively expressed efflux
proteins may conceal the function of the moderately expressed
BC4707. Alternatively, a compensatory mechanism may be
induced that masks the necessity for the BC4707 efflux protein.
Microarray analysis was therefore carried out in mid logarithmic
phase at OD600 0.5 of cells growing in LB medium (WT
OD0.5,
mutantOD0.5), comparing the wild type and the BC4707 deletion
mutant (Arrayexpress accession number E-MEXP-3537). The
results (Fig. 4 and Table 3) revealed that although the Dbc4707
mutant and the wild type displayed the same growth rate, 27 genes
were differentially regulated, at least 1.5 fold at OD600 0.5.
Thirteen genes were up-regulated, whereas 14 genes were down-
regulated, thus indicating a potential role for BC4707 in the
normal physiology of B. cereus ATCC14579 under exogenously
non-stressful conditions, most likely by relieving the cell of toxic
metabolites.
Phenotype analyses did not identify a condition where
BC4707 is essential
To screen for potential substrates or conditions where BC4707
is essential, or has a major role, Phenotype MicroArrayTM
experiments were conducted. In these experiments, the metabolic
activity was compared between the Dbc4707 mutant and the wild
type strain in 672 different conditions, including peptide nitrogen
sources, carbon sources, and pH. There were no consistent
differences in metabolic activity between the wild type and mutant
under any of the conditions (PM plates 1, 2, 6–8 and 10) testing for
carbon source, peptide nitrogen source or pH preferences (data
not shown).
To complement the phenotype microarray, growth tests were
conducted in minimal medium using different compounds as sole
carbon and/or nitrogen sources. The growth experiments were
initially carried out in liquid cultures, but the OD600 measure-
ments failed to give a reading, since bacteria exclusively grew as
aggregates on the glass at the air-liquid interface. To circumvent
this problem, subsequent experiments were carried out on GGGS-
agar plates. In agreement with the phenotype microarrays, no
consistent differences were found between the Dbc4707 mutant
and the wild type in growth behaviour (data not shown). There
were indications of a small difference in motility behavior on
GGGS plates, where the mutant appeared to be more motile than
the wild type. However, a consistent difference between the wild
type and mutant could not be confirmed on swarming or
swimming plates (data not shown).
Expression of the bc4707 gene in Escherichia coli
Although bc4707 expression is induced under bile salts stress
[21] as well as under acetic acid shock [22], the protein is not
essential for growth under such conditions (Fig. 1, Table 1 and
data not shown). Sequence similarity has classified BC4707 as a
multidrug transporter of the Major Facilitator Superfamily [12].
Deletion of bc4707 from B. cereus ATCC14579 only affected
growth of the mutant in one of 12 tested toxic compounds. It is
likely that redundancy among efflux proteins conceal an eventual
multidrug transport ability of BC4707. A common and sensitive
method to demonstrate multidrug transport capacity in a
membrane protein is by testing for increased drug tolerance after
heterologues expression in an E. coli strain that is hypersensitive to
multiple drugs. For this purpose, the gene (bc4707) was cloned into
the E. coli expression vector pTTQ18 as described previously [26].
The resulting plasmid potentiates IPTG inducible heterologous
expression of a BC4707-RGSHis6 tag fusion protein in E. coli.
Induction of protein expression with IPTG yielded a relatively
high level of BC4707-RGSHis6 in the membranes of the
expression host BL21 (DE3), as demonstrated by Coomassie Blue
staining as well as Western blotting using an antibody raised
against the RGSHis6 tag (Fig. 5 a and b). The observed molecular
weight of the BC4707-RGSHis6 protein after SDS-PAGE (Fig. 5)
was substantially lower (35 kDa) than that (52.5 kDa) predicted
from the amino acid sequence, a common feature for membrane
proteins [27,28]. The protein was solubilized from the inner
membrane of the E. coli host using the detergent dodecyl–beta-D-
Figure 3. Growth of B. cereus ATCC14579 and expression analysis of bc4707. A. Bacteria were grown in LB-medium. Circles indicate OD600
measurements. Bacteria were harvested for RNA extraction (open circles). B. Gene expression analysis of bc4707 by qRT-PCR. Averages and standard
deviations from three experiments are shown. The relative expression at different OD600 values is compared to the expression level at OD600 of 0.05.
16S RNA was used as a control to normalize the data.
doi:10.1371/journal.pone.0036720.g003
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maltoside (DDM) and purified to approximately 90% homogene-
ity by immobilized metal affinity chromatography (IMAC) as
described in Materials and Methods (Fig. 5 c). The impurities
detected by Coomassie staining in the purified protein fraction,
likely represent histidine-containing host proteins that co-purified
with the target protein [29]. Two protein bands in addition to the
target one of 35 kDa repeatedly showed up onWestern blots (Fig. 5
d). The band of higher molecular weight than the target, probably
represented the completely unfolded form of BC4707-RGSHis6
[27], whereas the faint band of lower molecular weight is likely a
degradation product of the target protein. Edman degradation
confirmed that the N-terminal amino acid sequence of the protein
that was detected as the major band on the Coomassie stained gel
was the B. cereus BC4707 protein (data not shown).
The integrity of the purified protein was further demonstrated
by circular dichroism (CD) measurements. Negative bands at
208 nm and 222 nm and a positive band at 193 nm indicated
predominantly a-helical secondary structure (Fig. 6), which is
consistent with the predicted topology of BC4707 of 14 a-helices
(data not shown). These experiments demonstrated that BC4707
was expressed as a full sized RGSHis6 fusion protein in E. coli and
that the protein localized to the membrane verifying the integrity
and localization of the protein upon heterologues expression.
BC4707 is a multidrug transport protein
E. coli DH5a DacrAB contains a deletion in acrA encoding a
membrane fusion protein and acrB encoding a multidrug efflux
system protein causing inactivation of the RND-transporter
complex, which results in an E. coli mutant that is hypersensitive
to many toxic compounds compared to the wild type [30–33].
This permits sensitive functional characterization of multidrug
transporters following their expression from a plasmid [34,35].
The presence of pBC4707 in E. coli DH5a DacrAB resulted in
improved tolerance to 3 of 12 tested xenobiotics compared to the
strain carrying the empty vector, pTTQ18 (Table 4). Increased
expression of BC4707-RGSHis6 by IPTG induction resulted in
even higher tolerance to the fluoroquinolones ciprofloxacin and
norfloxacin, whereas no further tolerance to kanamycin was
observed (Table 4). It is possible that the increased tolerance to
kanamycin in the pBC4707 carrying strain is due to leaky
expression of BC4707-RGSHis6 prior to the addition of kanamy-
cin, which potentiates drug expulsion. The reason there was no
further increase in tolerance after IPTG induction could be that
since kanamycin and IPTG was added simultaneously inhibition
of protein translation by kanamycin could have prevented further
increase of BC4707-RGSHis6 in the membrane.
Transport by BC4707 utilizes metabolic energy
The classification of BC4707 as an MFS protein implies that it is
a secondary active transporter for efflux driven by the cation
gradient, probably H+ built up during cell respiration [36]. To test
if the function of BC4707 is dependent on an intact proton
gradient a norfloxacin accumulation assay was performed in E. coli
(Fig. 7). Cells expressing BC4707-RGSHis6 had lower fluorescence
intensity compared to cells carrying the empty plasmid pTTQ18,
indicating that the presence of BC4707-RGSHis6 prevents
accumulation of norfloxacin in the cells, most likely via active
efflux of the drug (Fig. 7). Carbonyl cyanide 3-chlorophenylhy-
drazone (CCCP) is a protonophore that destroys the proton
gradient [37–39]. Addition of CCCP to the assay buffer resulted in
increased accumulation of norfloxacin in cells, and the increase in
accumulation is relatively more pronounced in the cells expressing
BC4707-RGSHis6 (Fig. 7), indicating that efflux mediated by
BC4707-RGSHis6 is dependent on an intact proton gradient.
Taken together these data demonstrate that BC4707, as predicted
by in silico analysis, is a multidrug efflux protein driven directly or
indirectly by the proton motive force.
Transcription analyses demonstrate that the expression
level of bc4707 is not altered in response to sub-lethal
concentrations of selected drugs
The susceptibility assay of E. coli DH5a DacrAB indicate that
BC4707 has the capability to transport xenobiotics such as
fluoroquinolones and possibly kanamycin, whereas the suscepti-
bility assay in B. cereus ATCC14579 showed involvement of
BC4707 in norfloxacin tolerance. We therefore tested the
transcriptional level of BC4707 in B. cereus in the presence and
absence of the drugs. B. cereus ATCC14579 was grown in LB
medium to logarithmic phase (OD600 of 0.5), norfloxacin,
ciprofloxacin or kanamycin were added and the culture was
incubated for 15 minutes followed by RNA extraction. Quantita-
tive RT-PCR-analysis (using 16S RNA as reference) indicated that
bc4707 transcription was not significantly affected by stress with
these antibiotics compared to an unstressed control (Fig. 8).
Similar results were obtained using GatB RNA [40] as reference
(data not shown).
Discussion
Previous results mapping the stress response induced by bile salt
in B. cereus [21] indicated a role for BC4707 in bile salts tolerance.
By contrast, phenotype analyses comparing the response of B.
cereus ATCC14579 and its isogenic Dbc4707 mutant to bile salt-
induced stress showed that BC4707 is not vital for B. cereus under
these conditions (Fig. 1 and Table 2). This suggests that the cells
either compensate for the absence of BC4707 under bile salt stress
or it is a minor contributor to the bile salt protection under the
conditions tested. Microarray analyses comparing the bile salts
stress responses of the wild type and Dbc4707 mutant did not
reveal major compensatory alterations in gene expression
(Table 1). The general conclusion is therefore that BC4707 does
Figure 4. COG distribution of differentially regulated genes in
exponentially growing Dbc4707 mutant and wild type. The
proportion of genes belonging to a COG class is shown as percentage
of the total number of differentially regulated genes. Open bars indicate
downregulated genes in the mutant compared to the wild type , solid
bars represent upregulated genes. i. the proportion of regulated genes
that are poorly characterized, ii. the proportion of genes with a
predicted function in cellular processes and signaling, iii. the proportion
of genes involved in information storage and processing, iv. the
proportion of regulated genes involved in metabolism and transport.
doi:10.1371/journal.pone.0036720.g004
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not have a significant role in the defense of B. cereus against bile
salts stress.
Similarly, it has been shown that bc4707 expression is induced
under acetic acid shock [22] but direct comparison of the Dbc4707
mutant and the wild type failed to demonstrate a major role for
BC4707 under this condition (data not shown). Taken together,
these experiments show that although transcriptional data
suggested participation of BC4707 in protecting B. cereus
ATCC14579 against bile salt stress and acetic acid stress, which
are two conditions that enteropathogenic bacteria theoretically
would encounter, it is not essential under these conditions.
Functional characterization of BC4707 in E. coli DH5a DacrAB
confirmed the in silico prediction that it is a secondary metabolite
multidrug transporter (Fig. 7, Table 4). Yet, the deletion of bc4707
in B. cereus failed to confirm a major role in multidrug transport
(Table 2). The Dbc4707 strain had a somewhat increased
susceptibility to only one (norfloxacin) of 12 tested xenobiotics
compared to the wild type. It is likely that the reason for this
discrepancy is due to the vast number of multidrug transporters in
B. cereus; these may offer elasticity to the antibiotic stress response
and conceal the contribution of the moderately expressed BC4707
under the tested conditions. Moreover, transcriptional data
showed that BC4707 expression is not induced by norfloxacin,
ciprofloxacin or kanamycin stress, indicating that BC4707 only
protects against these antibiotics when it is already present in the
membrane. Therefore it is possible that the involvement of
BC4707 in multidrug transport is small under specific conditions,
but may be physiologically relevant to the bacteria under other
conditions. The effect of bc4707 inactivation on norfloxacin
tolerance in addition to the increased tolerance of E. coli DH5a
DacrAB expressing BC4707-RGSHis6 suggests that BC4707 is
involved in protecting the cells against the action of at least some
fluoroquinolone compounds. The potential involvement of mem-
brane transport proteins in fluoroquinolone resistance by members
of the Bacillus cereus group of bacteria is becoming increasingly
evident. It was recently reported that during ciprofloxacin stress of
Table 3. Transcriptional profile of B. cereus ATCC14579 Dbc4707 (AH1598) compared to wild type (AH1709) under logarithmic
growth (OD600,0.5) in rich medium.
Gene Predicted protein function Dbc4707/WT
(fold change)
bc0579 malate sodium symporter 2.06
bc0580 malate dehydrogenase 1.61
bc0659 ribose operon repressor 1.54
bc0660 ribokinase 1.52
bc0662 ribose ABC transporter, ATP-binding protein 1.52
bc0872 cystine-binding protein 0.41
bc0873 cystine permease protein 0.39
bc0874 cystine ATP-binding protein 0.44
bc0909 oligopeptide ABC transporter, permease protein 0.63
bc0942 hypothetical protein 0.65
bc1034 glycerol uptake facilitator protein 2.12
bc1035 glycerol kinase 1.53
bc1251 dihydrolipoamide acetyltransferase 1.59
bc1252 2-oxoglutarate dehydrogenase, E1 component 1.57
bc1739 proton/sodium-glutamate symporter 1.65
bc2045 hypothetical protein 1.68
bc2300 oxalate:formate antiporter, putative 1.57
bc3718 PTS system, fructose-specific IIABC component 0.60
bc3719 1-phosphofructokinase 0.60
bc3720 transcriptional regulator, DeoR family 0.41
bc3760 6-phospho-beta-glucosidase 0.59
bc4242 proton/sodium-glutamate symporter 0.47
bc4366 cystathionine beta-lyase 0.52
bc4367 cystein synthase A 0.50
bc4368 59-methylthioadenosine/S-adenosylhomocysteine nucleosidase 0.56
bc4369 Dimethyladenosine transferase 0.47
bc4396 molybdopterin biosynthesis protein 0.64
bc4707 drug resistance transporter, EmrB/QacA family 0.38
bc4789 S-ribosylhomocysteinase 0.65
bc5239 enterotoxin/cell wall binding protein 1.80
Bold text indicates that the gene is differentially regulated more than or equal to two times (i.e. the values are $2 or #0.5).
doi:10.1371/journal.pone.0036720.t003
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B. anthracis, the gene GBAA0834, a TetR type transcriptional
regulator was a hotspot for mutations leading to ciprofloxacin
resistance. As a consequence of mutations leading to disruption of
GBAA0834, several adjacent multidrug transporters were up
regulated and were probably responsible for the increased
ciprofloxacin tolerance [41]. These findings are of concern, since
fluoroquinolones are the first line of antimicrobial compounds
used in the treatment of B. anthracis infections [42,43].
Although norfloxacin transport is an important function for
BC4707 from a clinical perspective, it is likely not the original
native function. A BLAST search showed that chromosomally
encoded orthologues of BC4707 with high amino acid identity
(.91%) exist in all 88 members of the B. cereus group of bacteria
that have been sequenced to date (data not shown), indicating this
gene as being part of the core genome with an ancient and
conserved function. Fluoroquinolone compounds, on the other
hand are synthetic drugs, first introduced in the early 1960s.
Multidrug transporters have been shown to have additional
Figure 5. Expression and purification of BC4707-RGSHis6. Protein expression was induced for 3 hours by addition of IPTG (1 mM) to
exponentially growing bacteria. Cells were harvested and mixed membrane preparations were made from each culture. The proteins in the mixed
membrane fractions prepared by the water-lysis technique [47] were separated by SDS-PAGE and detected by: (A) Coomassie Blue stain; or (B)
Western blotting with an antibody to the RGSHis6-tag (+ and 2 represent mixed membrane preparations of induced and uninduced cells,
respectively). Purification of BC4707-RGSHis6 was done by immobilized metal affinity chromatography (IMAC). Staining with Coomassie Blue (C)
shows the enrichment and purity of BC4707-RGSHis6 at different stages of purification. The gel was loaded as follows: 1) molecular weight marker 2)
inner membranes solubilized in dodecyl-beta-D-maltoside detergent; 3) supernatant of the solubilized inner membranes after ultracentrifugation; 4)
pellet of the solubilized inner membrane fraction after ultracentrifugation; 5) flow-through after IMAC-binding; 6) elution fraction (5 mg protein).
Western blot (D) of the final elution fraction (7.5 mg protein). The sizes of the bands in the molecular weight markers are indicated.
doi:10.1371/journal.pone.0036720.g005
Figure 6. SRCD analysis of purified BC4707-RGSHis6 protein.
CD spectral analysis of BC4707-RGSHis6 was performed over 260-
170 nm at 1 nm intervals with an integration time of 1 s. The spectrum
shown is buffer subtracted and is an average of 10 scans. The dashed
line represents the HT voltage at the photomultiplier.
doi:10.1371/journal.pone.0036720.g006
Table 4. Susceptibilities of E. coli DH5a DacrAB expressing
bc4707 (pBC4707) compared to its vector control (pTTQ18)
under uninduced (LB (0 mM IPTG)) and induced (LB (0.05 mM
IPTG)) conditions.
MIC (mg/ml) MIC (mg/ml)
LB (0 mM IPTG) LB (0.05 mM IPTG)
E. coli DH5a DacrAB E. coli DH5a DacrAB
Compound pTTQ18 pBC4707 1 pTTQ18 pBC4707 1
Chloramphenicol 0.3125 0.3125 1 0.3125 0.3125 1
Ciprofloxacin 0.01 0.04 4 0.01 0.16 16
Bile salts 3200 3200 1 3200 3200 1
Deoxycholate 1600 1600 1 1600 1600 1
SDS 50 50 1 50 50 1
Crystal violet 0.25 0.25 1 0.25 0.25 1
Kanamycin 2.5 10 4 2.5 10 4
Nalidixic acid 30 30 1 30 30 1
Erythromycin 3.13 3.13 1 3.13 3.13 1
Ethidium bromide 2.5 2.5 1 2.5 2.5 1
Norfloxacin 0.08 0.32 4 0.08 1.28 16
Tetracycline 1.56 1.56 1 1.56 1.56 1
1represents the fold difference in MIC between the E. coli DH5a DacrAB
(pBC4707) strain compared to the vector control (DH5a DacrAB (pTTQ18)).
doi:10.1371/journal.pone.0036720.t004
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fundamental physiological functions in addition to the multidrug
transport capability [17–19,23–25]. Furthermore, it has been
speculated that environmental stress from conditions in the natural
habitat of bacteria may be responsible for the conservation of
multidrug transporters and the spread of multidrug resistant
bacteria [44]. It is likely that the fluoroquinolone transport
capability of BC4707 is an additional effect to the original native
function. Based on this it was hypothesized that the reason
BC4707 is conserved in all members of the B. cereus group is due
to an indigenous function that is important in the natural
environment of the bacteria.
Attempts using phenotype experiments comparing the wild type
and Dbc4707 mutant under a range of stressful conditions,
including metabolic stress, different salt conditions and pH, failed
to elucidate an essential indigenous role of BC4707 in the normal
physiology of B. cereus. The microarray data from comparison of
the wild type and Dbc4707 mutant during exponential growth in
rich medium showed differential regulation of a set of genes
involved in metabolism of cysteine, as well as alternative carbon
sources (Table 3). We hypothesized that the differential regulation
of these genes may reflect a compensatory mechanism to
counteract accumulation of toxic metabolites. It is possible that
this compensation is enough to sustain normal growth of the
mutant in the absence of BC4707. Alternatively, the difficulty in
identifying an alternative role for BC4707 in addition to multidrug
transport is due to redundancy among the encoded multidrug
transporters at the conditions tested. It is likely that inactivation of
additional efflux proteins is required in order to clarify the role of
BC4707 in the normal physiology of B. cereus as well as in the
potential multidrug transport.
Materials and Methods
Bacterial strains and plasmids used in this study are listed in
table 5. If not otherwise stated, culture conditions were LB
medium at 30uC and 220 rpm.
Construction of mutants
The E. coli DH5a DacrAB mutant was constructed according to
the l-Red recombinase based method described by Datsenko and
Wanner [45]. Briefly, approximately 300 ng of processed PCR
product was introduced by electroporation into E. coli DH5a
containing pKD46, which expresses l-Red recombinase. The
PCR product was amplified from pKD3 and consists of a
chloramphenicol cassette flanked by FRT-sites and approximately
40 bp homologous to the 59 end of acrA as well as the 39 end of
acrB. Primers used in the study are listed in Table 6. Recovered
colonies carrying the chloramphenicol cassette in place of acrAB
were purified twice on LB agar containing chloramphenicol
(20 mg/ml). A markerless mutant was constructed by introducing
the pCP20 plasmid encoding a FLP-recombinase into the
chloramphenicol resistant mutant followed by screening for
antibiotic sensitive mutants. Recovered colonies were purified
twice on LB agar. The mutation was confirmed by sequencing.
A markerless knock-out mutant in B. cereus ATCC14579 was
constructed essentially as described by Janes & Stibitz [46]. Briefly,
the fused up- and downstream regions flanking bc4707 were
amplified by PCR and introduced into the suicide shuttle vector
pBKJ236. The vector contains the recognition site for the homing
endonuclease I-SceI. After transformation, pBKJ236 was incorpo-
rated into the chromosome of B. cereus via homologous recombi-
nation. Selection of recombinants were done on LB plates
containing erythromycin (5 mg/ml) and was facilitated by the
temperature sensitive origin of replication in pBKJ236 which does
not permit replication of the plasmid at 37uC. Following
transformation of a second plasmid (pBKJ223) carrying the gene
encoding the homing endonuclease I-SceI, double strand breaks
were introduced in the chromosome at the site of the inserted
plasmid. The double strand breaks force homologous recombina-
tion events to repair the DNA damage which results in either wild
type or mutant genotypes. Recombinants that had undergone the
second recombination step were identified as erythromycin
sensitive colonies. Screening for markerless mutants was done by
PCR amplification using primers annealing up- and downstream
of bc4707. The mutation was confirmed by sequencing.
Figure 7. Accumulation of Norfloxacin in E. coli DH5a DacrAB
(pBC4707) and DH5a DacrAB (pTTQ18). The fluorescence of
intracellularly accumulated norfloxacin was measured at 280 nm
excitation and 445 nm emission in the supernatant of bacterial extracts.
Bacteria expressing BC4707-RGSHis6 are indicated by circles whereas
bacteria carrying the empty vector are shown as diamonds. The assay
was started by the addition of 100 mM norfloxacin at time 0 min. At
15 min, the protonophore CCCP (100 mM) was added to disrupt the
proton motive force. Shown are averages and standard deviations from
two independent experiments.
doi:10.1371/journal.pone.0036720.g007
Figure 8. Relative expression of bc4707 in stressed cells
compared to unstressed cells. The expression level of bc4707 was
measured by qRTPCR and was normalized against the expression of16S
RNA. The values shown are ratios of the normalized expression levels of
cells stressed with antibiotics for 15 min compared to unstressed cells.
Shown are averages and standard deviations of at least two
independent experiemnts each done with two technical replicates.
doi:10.1371/journal.pone.0036720.g008
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Table 5. Strains and plasmids used in this study.
Strains or plasmids Relevant genotype or description Source or reference
Bacillus cereus strains
ATCC14579 Wild type Laboratory collection
AH1598 ATCC14579 Dbc4707 (pBClin152) This study
AH1709 ATCC14579 (pBclin152) This study
Escherichia coli strains
BL21 (DE3) F2 ompT hsdSB(rB
2 mB
2) gal dcm (DE3) Novagen
DH5a endA1 hsdR17 supE44 thi-1 recA1 gyrA relA1 D (lacZYA-
argF)U169 (w80lacZDM15)
Laboratory collection
AH1805 DH5a DacrAB This Study
Plasmids
pTTQ18 E. coli expression plasmid, Ampr [26]
pBC4707 pTTQ18[PlacIQ/bc4707] This study
pBKJ236 E. coli-Bacillus shuttle vector, Eryr, Ori(Ts) [46]
pBKJ236_bc4707 pBKJ236[Dbc4707] This study
pBKJ223 [Pamy/IsceI], Tetr [46]
doi:10.1371/journal.pone.0036720.t005
Table 6. Primers used in this study.
Purpose and name Sequence
Construction of KO-mutants
B. cereus ATCC14579
AV19_upBC4707_Xba_F_II CTATCTAGAATTTCGGCCTATCTGGACCT
AV20_upBC4707_SalI_R_II ATAGTCGACCATTTGTTTTCCCCTTACCC
AV9_downBC4707_SalI_F_new ATGTCGACTAAAAAGGATGACCATTTTGGTCATCCT
AV10_downBC4707_PstI_R_new ATACTGCAGCCATTTGGGCCATCACCATGTAA
E. coli DH5a
acrAB-KO-Start ATGAACAAAAACAGAGGGTTTACGCCTCTGGCGGTCGTTCGTGTAGGCTGGAGCTGCTTC
acrAB-KO-Stop TGTGCTCGATATCTTCATTCTTGCGGCTAAAGCGGCGGCGCATATGAATATCCTCCTTAGT
Sequencing of pBKJ236Dbc4707
pBKJ236_MCS_1 ACACTTTATGCTTCCGGCTC
pBKJ236_MCS_2 CAGTCTATCCCCTGGCGAA
Sequencing of KO-mutants
Bacillus cereus Dbc4707
AV55_forwKO4707_1CO GTGACCGCTCATTACAAGGTC
AV59_revKO4707_2CO ATGTTGTAACGCCGAGTAAAGG
E. coli Dh5a DacrAB
acrAB-KO-control-for CATCGAGGATGTGTTGGC
acrAB-KO-control-rev TTTGGGTGAGTATTCATCCAT
Construction of pBC4707
Bc4707-Forward_EcoRI CCGGAATTCGCATATGAGAAAAAAAGTCATGATGTCTTTAATGTT
Bc4707-Reverse_PstI AAACTGCAGCTTGTTGCTCACTTGTTTGTGTAGCTGGCTTTAATA
Sequencing of pBC4707
pTTQ18-MCS-start TTGCGCCGACATCATAACG
pTTQ18-MCS-stop CCTCTTCGCTATTACGCCA
doi:10.1371/journal.pone.0036720.t006
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Construction of the E. coli expression vector pBC4707
The gene bc4707 was amplified by PCR from genomic DNA
extracted from the B. cereus type strain ATCC14579 using the primers
Bc4707-forward_EcoRI and Bc4707-reverse_PstI (Table 6). The
PCR product was cloned into the plasmid pTTQ18 by restriction
digestion using EcoRI and PstI and ligation using T4-DNA ligase
(New England Biolabs). Ampicillin resistant colonies were clean
streaked twice and the vector insert was verified by sequencing.
Expression of BC4707-RGSHis6 and preparation of
membrane fractions
Optimization of protein expression in E. coli BL21 (DE3)
(pBC4707) was done in 100 ml cultures at 37uC, 150 rpm. IPTG
(0–1 mM) was added to the cultures in the mid-logarithmic growth
phase (OD600 of 0.4–0.6). Protein expression was induced for 3 h.
The bacterial cells were disrupted by the water-lysis method [47]
and the membrane fraction was prepared as described previously
[47]. For large scale production of BC4707-RGSHis6, E. coli BL21
(DE3) (pBC4707) was grown in a 30 liter culture in a fermenter at
37uC. Protein expression was induced for 3 h following addition of
1 mM IPTG at OD600 0.4–0.6. Bacterial cell disruption was
achieved by explosive decompression in a Constant Cell Disrup-
tion System (WWW.constantsystems.com). Inner membranes were
prepared as previously described [47].
Solubilization and purification of the BC4707-RGSHis6
membrane protein
E. coli inner membranes containing overexpressed BC4707-
RGSHis6 were added to solubilization buffer [20 mM Tris
pH 8.0, 30 mM imidazole pH 8.0, 300 mM NaCl, 20% glycerol,
1% dodecyl-beta-D-maltoside (DDM)] to give a final protein
concentration of 3 mg/ml. The suspension was incubated at 4uC
for a minimum of 1 hour with gentle mixing. Insoluble proteins
were removed by ultracentrifugation at 100,0006 g for 1 hour at
4uC. The solubilized protein was added to the Ni-NTA resin
(QiagenTM, Germany) and incubated for a minimum of 1.5 hours
at 4uC with gentle mixing. The unbound protein was allowed to
run off and the protein-bound resin was washed with 106 resin
volumes of wash buffer (20 mM Tris pH 8.0, 30 mM imidazole,
10% glycerol, 150 mM NaCl, 0.05% DDM) and eluted using
imidazole elution buffer (20 mM Tris pH 8.0, 200 mM imidazole,
5% glycerol, 150 mM NaCl, 0.05% DDM). The eluted protein
was concentrated using a Vivaspin 20 (100 kDa MWCO)
concentrator (Sartorius Ltd., Epsom, UK) and desalted using a
Econo-PacH 10DG desalting gel column (BioRad, California,
USA) to remove any extraneous imidazole remaining from the
elution step. The concentrated protein was analyzed immediately
or stored at 280uC.
Preparation and analysis of samples by Synchrotron
Radiation Circular Dichroism spectroscopy
Purified BC4707-RGSHis6 protein was resuspended to a final
concentration of 0.5 mg/ml in CD buffer (10 mM potassium
phosphate, pH 7.6; 0.05% DDM) and the sample placed into a
0.02 cm pathlength circular cell. CD measurements were
performed on Beamline B23 (Diamond Light Source, Didcot,
UK) at 18uC. Data points were recorded at over 260-170 nm at
1 nm intervals with an integration time of 1 s. A spectrum of the
CD buffer was taken and subtracted as background.
RNA isolation
Bacterial cells were harvested by diluting the cultures with an
equal volume of ice-cold methanol followed by centrifugation at
4,000 g for 5 min at 4uC. Cells were disrupted using a
PrecellysH24 tissue homogenizer. RNA isolation was performed
using the RNeasy Mini Kit (Qiagen, Germany) according to the
manufacturer’s protocol, including the optional on column DNAse
treatment. After elution, the RNA was treated with Turbo DNAse
(Applied Biosystems, USA) according to the manufacturer’s
manual followed by a second round of purification using the
RNeasy Mini Kit. The concentration of RNA was determined by
UV-spectrometry and the quality was controlled by agarose gel
electrophoresis as well as UV-spectrometry.
Quantitative RT-PCR
Complementary strand DNA was synthesized from 1 mg of
RNA using the Superscript III reverse transcriptase (Invitrogen)
according to the manufacturer’s instructions. The cDNA was
diluted 1:5 (1:2500 for the reference gene 16S). Three microliter of
diluted cDNA was mixed with primers (0.5 mM) as well as
qPCR&GOTM LC480 green master mix (MPBiomedicals, USA)
to a final volume of 15 ml. Primers were designed to result in an
amplicon of approximately 100 bp (Table 6). Quantitative PCR
was performed with a Roche Lightcycler 480 (Roche Diagnostics
GmbH, Germany). The cycling conditions were 95uC for 1.5 min
followed by 45 cycles at 95uC for 10 seconds, 58uC for 10 seconds
and 72uC for 10 seconds. The crossing point (Ct) values were
determined by the 2nd derivative maximum of two technical
replicates per biological replicate. Results were calculated by the
DDCt approximation. Expression ratios are averages of at least 2
biological replicates including 2 technical replicates using 16S as
the reference gene for normalization. In addition, GatB RNA was
used as reference to confirm the results.
Microarray analysis
The microarray slides, containing 70-mer oligonucleotides
representing all the genomic ORFs of B. cereus (ATCC14579),
were printed at the Microarray core facility of the Norwegian
University of Science and Technology (NTNU) in Trondheim.
The microarray experiments were conducted as previously
described by Gohar et al. [48]. Briefly, the microarray slides were
pre-incubated at 42uC for 45 minutes in pre-hybridization buffer
(56SSC, 0.1% SDS, 0.1% BSA); washed in MQ water followed by
isopropanol and finally spun dry. Complementary strand DNA
synthesis, labeling and purification was carried out with the
FairPlay IIITM microarray labeling kit (Stratagene, USA), using
500 ng random hexamers (Applied Biosystems, USA), 20 mg of
RNA, and Cy3 or Cy5 dyes (GE Healthcare Bio-Sciences AB,
Sweden). After purification, the samples were concentrated with a
Microcon column (Millipore, USA). Labeled DNA was mixed with
hybridization solution (30% formamide, 56SSC, 0.1% SDS and
0.1 mg/ml salmon sperm DNA) denatured at 95uC for 2 minutes,
and incubated at 42uC before hybridization. Hybridization was
carried out over night at 42uC in a hybridization chamber
(Monterey Industries, CA, USA) humidified with 56SSC. After
hybridization, the slides were washed at 42uC in a buffer
containing 0.56SSC and 0.01% SDS followed by 0.066SSC,
and finally in isopropanol before they were spun dry. The slides
were scanned with an Axon 4000B scanner using the GenePix Pro
6.0 software (Molecular Devices, CA, USA). Microarray data was
analyzed with a custom R-script in R 2.10.1 [49]. The GenePix
files were imported to R, and the Limma package [50] was used
for filtering, normalization, and further analysis. Microarray
experiments were conducted with two independent experiments
analyzed in two dye swapped technical replicates each. The
Microarray data are available in the ArrayExpress database (www.
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ebi.ac.uk/arrayexpress) under accession numbers E-MEXP-3529,
E-MEXP-3535, E-MEXP-3536 and E-MEXP-3537.
Susceptibility assays
Bacteria were grown in LB medium at 30uC, 220 rpm overnight,
diluted 1:100 into a pre-culture and incubated at the same
conditions until mid-logarithmic phase (OD600,0.5). The pre-
culture was diluted to OD600 of 0.02 and distributed in 100 ml
aliquots in the wells of 96 wells plates (Becton Dickinson Labware,
Franklin Lakes, USA). Compounds were added to the wells at
appropriate concentrations in 26 dilution series from 1006
concentrated stock solutions. For susceptibility assays using E. coli
DH5a DacrAB carrying pTTQ18 or pBC4707, ampicillin (100 mg/
ml) was included in the medium. These assays were carried out in
protein expression uninduced (0 mM IPTG) as well as induced
(0.05 mM IPTG) conditions. The plates were incubated at 30uC,
220 rpm for 20 h and then analyzed by ocular inspection as well as
by a VictorTM6multilabel plate reader (Perkin-Elmer) at 595 nm.
Minimum inhibitory concentrations were determined as the
concentration of xenobiotics at which the OD after 20 h incubation
was less than double the starting OD. In case visual inspection
showed aggregated cells at the bottom of the wells in otherwise
transparent media, the OD measurements were considered
unreliable whereas the MIC value was determined as the
concentration where the media turned from turbid to transparent.
In most cases, the two methods to determine the MIC correlated.
Growth in GGGS medium
Bacterial growth under nutrient poor conditions was tested
using a minimal medium derived from GGGS medium [51]. The
composition of the medium was K2HPO4 (3.0 mM), KH2PO4
(3.5 mM), MgSO4 (0.8 mM), MnCl2 (0.04 mM), NaCl (0.2 mM),
CaCl2 (0.2 mM), ZnCl2 (0.05 mM), and FeCl3 (0.04 mM). In
addition to this, 2 mM nitrogen source as well as 20 mM carbon
source was added. Combinations of 7 different nitrogen sources
and 6 different carbon sources were tested. The carbon sources
investigated were: glucose, lactate, maltose, sorbitol, galactose,
pyruvate, and xylose. The nitrogen sources investigated were: L-
serine, L-glutamate, L-arginine, L-proline, urea and ammonium
chloride. Bacteria were grown overnight in LB medium at 30uC
and 220 rpm shaking. The culture was diluted 1:100 in fresh LB
medium and cultured under the same conditions until mid-
logarithmic phase. The bacteria were washed once in GGGS
medium and resuspended in fresh GGGS medium including
nitrogen and carbon sources to an OD600 of 0.01. Initially,
attempts were made to establish growth curves for the mutant and
wild type. The cultures were incubated in 100 ml Erlenmeyer
flasks filled to a fourth of the volume, at 220 rpm at 30uC for up to
140 h. The absorbance was measured at regular intervals. In a
subsequent experiment the bacterial suspensions (OD600 0.01 in
GGGS medium) were spotted onto 1.5% agar plates containing
GGGS medium supplemented with nitrogen and carbon sources.
These plates were incubated at 30uC for 140 h. Bacterial growth
was scored depending on the density and appearance of the
colonies.
Motility assays
Swimming motility was observed on 0.3% LB agar plates
whereas swarming motility was observed on 1.0% LB agar plates
supplemented with 0.5% glucose. The plates were inoculated with
5 ml of culture (OD600,5) that had been concentrated from a
logarithmically growing culture (OD600,1). Plates were incubated
at 37uC. The diameter of the zone created by the swimming
bacteria and the radius of the zone created by the swarming
bacteria respectively were measured at regular intervals for 70 h.
Similar experiments were conducted using 0.3% and 1.0% GGGS
agar plates supplemented with different combinations of carbon
and nitrogen sources as described above.
Phenotype microarray
Bacteria were inoculated onto tryptic soy agar (TSA), incubated
at 28uC over night and clean streaked onto TSA for an additional
over night incubation. Single colonies, picked using sterile cotton
swabs, were suspended in inoculation fluid (IF-0, Biolog, Hayward,
CA, USA). The transmittances of the bacterial suspensions were
adjusted to 85% on a Biolog turbidometer. Cell suspension,
inoculation fluids, tetrazolium dye, and suitable additives were
mixed according to the manufacturer’s protocol optimized for
Bacillus subtilis. The mixture was inoculated into the Phenotype
Microarray plates (100 ml per well), which were incubated at 28uC
in an Omnilog reader. Quantitative color changes were recorded
every 15 min by a charge-coupled camera device for a period of
48 h. The kinetic responses were analyzed with the Omnilog-PM
software. The data was analyzed visually as well as by comparing
the calculated areas under the kinetic response curves.
Norfloxacin accumulation assay
Bacterial cells for the norfloxacin accumulation assay were
prepared by growing E. coli DH5a DacrAB (pBC4707) as well as E.
coli DH5a DacrAB (pTTQ18) at 37uC in LB broth containing
ampicillin (100 mg/ml) over night. The cultures were diluted to an
OD600 of 0.05 in fresh LB broth including ampicillin (100 mg/ml).
These cultures were grown to OD600,0.5, at which point IPTG
was added to a concentration of 0.1 mM. Expression of proteins
was induced for 3 hours. Following this, the cells were spun down,
washed twice in Tris-Cl (pH 7.0) including 100 mM NaCl and
resuspended in the same buffer. The OD600 was adjusted to 1 and
glucose was added to a final concentration of 20 mM. The assay
was started by the addition of 100 mM norfloxacin. Samples (1 ml)
were taken every five minutes for 30 min starting before (time
0 min) the addition of norfloxacin. CCCP (100 mM) was added at
time 15 min. Samples were centrifuged at 13000 rpm for
30 seconds, the supernatant was discarded. The bacterial pellet
was washed once in Tris-Cl (pH 7.0) including 100 mM NaCl and
resuspended in 0.1 M glycin (pH 3.0). The Norfloxacin was
extracted over night at 37uC. The bacterial debris was removed by
centrifugation and the fluorescence of the supernatant was
measured at 280 nm excitation and 445 nm emission on a
Perkin-Elmer LS-55 fluorescence spectrophotometer.
Acid stress
Acid stress experiments were conducted basically as described
by Mols et al. [22]. Pre-cultures of the B. cereus wild type as well as
the D4707 isogenic mutant were inoculated from overnight
cultures. The pre-cultures were grown until mid-logarithmic phase
(OD600 was between 0.5–1.0) at which point they were diluted
1:100 in brain heart infusion medium (BHI) buffered to pH 7.1
with 100 mM or 10 mM sodium phosphate. The buffered cultures
were grown to an OD600 of 0.5. At this point the medium was
acidified to pH 5.5 using 0.238% (v/v) 12 M hydrochloric acid,
0.69% (v/v) lactic acid, 0.205% (v/v) 12 M hydrochloric acid with
0.074% (v/v) acetic acid or 0.571% (v/v) acetic acid, respectively.
The OD600 of the cultures were recorded for an additional 4.5 h.
Supporting Information
Table S1 Bile salt induced transcriptional profiles of B.
cereus ATCC14579 and its isogenic Dbc4707 mutant.
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Bacteria were grown to OD600 0.5 (t
OD 0.5) at which point bile salts
(50 mg/ml) were added followed by additionally 15 min incuba-
tion (tBS 15). Cells were harvested and total RNA was prepared
from each strain before (tOD 0.5) and after (tBS 15) bile salts stress.
Microarray analysis was conducted comparing the gene expression
at time tBS 15 with time tOD 0.5. Shown are genes with significantly
(P,0.05) different relative expression (tBS 15/tOD 0.5.1.5 or tBS
15/tOD 0.5,0.67) in at least one strain after bile salts stress for
15 min. * indicates relative expression values that were not
statistically significant (i.e. p.0.05).
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